Bausch Health Com…
USUSDBausch Health Companies Inc (TO:BHC) — Biotechnology: Pharmaceutical Preparations. Numero di borse in cui sono quotate le azioni della società: 2. In questa pagina: prezzo e grafico, dividendi, principali azionisti e cronologia del numero di azioni.
Informazioni sull'Azienda
- Sito Web
- bauschhealth.com
- Relazioni con gli Investitori
- ir.bauschhealth.com/
- Settore
- Health Care · Biotechnology: Pharmaceutical Preparations
- Sede Centrale
- Laval, Canada
- Amministratore Delegato
- Joseph C. Papa
- Dipendenti
- 20 300
- Fondata
- 1960
- Quotata dal
- 03.04.1996 (TO:BHC)
- Azioni in Circolazione
- Flottante
- 260.57 Mln
- Capitalizzazione di Mercato
- 2.17 Mld USD
- Insider
- 11.12%
- Investitori Istituzionali
- 65.02%
- Settore (SIC)
- Pharmaceutical Preparations
- ISIN
- CA91911K1021
- LEI
- KOO0397YRO83WY5MGD97
- P/E
- perdita
- Payout Ratio
- perdita
- FCF
- 1.43 Mld USD
- Pagamenti / FCF
- 25%
- Debito
- 20.7 Mld USD13 anni di FCF
- Serie di Dividendi
- —
- Utili, FCF e dividendi pagati — per i 12 mesi fino a 30.06.2026 (l'ultimo rapporto dell'azienda).
- NAV
Descrizione
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Dividendi
Nessun pagamento di dividendi trovato (controllato 18.10.2026). Probabilmente la società non distribuisce dividendi.
Principali Azionisti
| Detentore | Quota | Azioni | Data del Rapporto |
|---|---|---|---|
| PAULSON JOHN A. (Directo… | ≈19.7% | 73.69 Mln | 2026-06-30 |
| PAULSON & CO., INC. (Ben… | 19.58% | 73.26 Mln | 2026-06-30 |
| Goldentree Asset Managem… | 9.27% | 34.67 Mln | 2026-06-30 |
| Royal Bank of Canada | 2.9% | 10.83 Mln | 2026-06-30 |
| Healthcare of Ontario Pe… | 2.14% | 8 Mln | 2026-06-30 |
| Vanguard Capital Managem… | 2% | 7.47 Mln | 2026-06-30 |
| Goldman Sachs Group Inc | 1.66% | 6.23 Mln | 2026-06-30 |
| MFN Partners Management,… | 1.6% | 6 Mln | 2026-06-30 |
| SG Americas Securities,… | 1.48% | 5.54 Mln | 2026-06-30 |
| Acadian Asset Management… | 1.47% | 5.48 Mln | 2026-06-30 |
| Kohlberg Kravis Roberts… | 1.4% | 5.24 Mln | 2026-06-30 |
| VANGUARD STAR FUNDS-Vang… | 1.01% | 3.76 Mln | 2026-04-30 |
| APPIO THOMAS J (Chief Ex… | ≈0.97% | 3.62 Mln | 2026-02-25 |
| VANGUARD TAX-MANAGED FUN… | 0.66% | 2.48 Mln | 2026-06-30 |
| SCHWAB STRATEGIC TRUST-S… | 0.38% | 1.41 Mln | 2026-05-31 |
| VANGUARD Intl Eqy. INDEX… | 0.26% | 957 190 | 2026-04-30 |
| DFA INVESTMENT TRUST CO-… | 0.22% | 815 010 | 2026-07-31 |
| CHARHON JEAN-JACQUES (Ch… | ≈0.2% | 755 538 | 2026-02-25 |
| CARSON SEANA LYNNE (Gene… | ≈0.16% | 616 761 | 2026-03-03 |
| SCHWAB STRATEGIC TRUST-S… | 0.15% | 542 712 | 2026-05-31 |
| DFA INVESTMENT DIMENSION… | 0.12% | 431 311 | 2026-04-30 |
| SPDR INDEX SHARES Fd.S-S… | 0.11% | 405 303 | 2026-08-31 |
| iShares Trust-iShares Co… | 0.1% | 377 486 | 2026-07-31 |
| iShares Trust-iShares Co… | 0.1% | 358 322 | 2026-07-31 |
| LENAR AIMEE J (Officer) | ≈0.09% | 334 853 | 2026-08-19 |
| WECHSLER AMY B (Director… | ≈0.08% | 313 585 | 2026-05-22 |
| POWER ROBERT N (Director… | ≈0.08% | 300 594 | 2026-05-22 |
| KAVANAGH SARAH BALDWIN (… | ≈0.08% | 282 230 | 2026-05-22 |
| MILLER STEVEN D (Directo… | ≈0.06% | 239 224 | 2025-05-16 |
